Literature DB >> 10721081

Radical scavenging properties of tryptophan metabolites. Estimation of their radical reactivity.

K Goda1, Y Hamane, R Kishimoto, Y Ogishi.   

Abstract

Radical scavenging properties of tryptophan metabolites were estimated using their radical reactivity. Metabolites of the kynurenine and the melatonin biosynthesis pathway were mainly examined by use of a kinetical model. Their radical reactivity was determined as the reaction rate constant with a stable free radical, such as galvinoxyl; that is a phenoxy radical. The rate constants of the metabolites have a widely ranged spectrum, which can be divided into three groups. The first group (3-hydroxykynurenine, 3-hydroxyanthranilic acid, and indole-3-pyruvic acid) is more reactive than alpha-tocopherol; the reactivity of the second group (xanthurenic acid, serotonin, N-acetylserotonin) is similar to that of butylated hydroxytoluene (BHT); the third group (kynurenic acid, melatonin, and other ones) is less reactive than BHT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10721081     DOI: 10.1007/978-1-4615-4709-9_50

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.

Authors:  Susanna Campesan; Edward W Green; Carlo Breda; Korrapati V Sathyasaikumar; Paul J Muchowski; Robert Schwarcz; Charalambos P Kyriacou; Flaviano Giorgini
Journal:  Curr Biol       Date:  2011-06-07       Impact factor: 10.834

2.  Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.

Authors:  Korrapati V Sathyasaikumar; Erin K Stachowski; Ikwunga Wonodi; Rosalinda C Roberts; Arash Rassoulpour; Robert P McMahon; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2010-10-29       Impact factor: 9.306

3.  A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.

Authors:  Flaviano Giorgini; Paolo Guidetti; QuangVu Nguyen; Simone C Bennett; Paul J Muchowski
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

Review 4.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

5.  Tryptophan in alcoholism treatment I: kynurenine metabolites inhibit the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol.

Authors:  Abdulla A-B Badawy; Samina Bano; Alex Steptoe
Journal:  Alcohol Alcohol       Date:  2011-09-06       Impact factor: 2.826

Review 6.  Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy.

Authors:  Kang Xu; Hongnan Liu; Miaomiao Bai; Jing Gao; Xin Wu; Yulong Yin
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

Review 7.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.

Authors:  Abdulla A-B Badawy
Journal:  Int J Tryptophan Res       Date:  2017-03-15

8.  Kynurenine aminotransferase activity of Aro8/Aro9 engage tryptophan degradation by producing kynurenic acid in Saccharomyces cerevisiae.

Authors:  Kazuto Ohashi; Romanas Chaleckis; Masak Takaine; Craig E Wheelock; Satoshi Yoshida
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

9.  Decreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase.

Authors:  Derin B Keskin; Brendan Marshall; David Munn; Andrew L Mellor; Debra A Gearhart
Journal:  Cell Mol Biol Lett       Date:  2006-11-13       Impact factor: 5.787

10.  Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.

Authors:  Carlo Breda; Korrapati V Sathyasaikumar; Shama Sograte Idrissi; Francesca M Notarangelo; Jasper G Estranero; Gareth G L Moore; Edward W Green; Charalambos P Kyriacou; Robert Schwarcz; Flaviano Giorgini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.